[{"Assets_0_Q1_USD":10933745000.0,"CommonStockSharesOutstanding_0_Q1_shares":223783675.0,"EarningsPerShareBasic_1_Q1_USD":-2.26,"EarningsPerShareDiluted_1_Q1_USD":-2.26,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":48846000.0,"NetIncomeLoss_1_Q1_USD":-505489000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":223521000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":223521000.0,"Ticker":"ENDP","CIK":"1593034","name":"ENDO INTERNATIONAL PLC","OfficialName":"Endo International plc Ordinary Shares","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"640358301.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180508"}]